Prior Authorization / Preferred Drug List (PA/PDL ...

Lomitapide is an inhibitor of P-glycoprotein (P-gp) and therefore concomitant administration of lomitapide may increase exposure of the P-gp substrate drug. Refer to table 7 for a list of potential drug-drug interactions and recommendations for avoidance of combinations with lomitapide or dose modifications. ................
................